West Pharmaceutical Services IncWST

Capital at risk.

Calendar
event
Ex dividend date
30 Apr 2025
calendar_clock
Next Dividend Payment
07 May 2025
About West Pharmaceutical Services Inc
Ticker
info
WST
Trading on
info
NYSE
ISIN
info
US9553061055
Industry
info
Medical Instruments & Supplies
Sector
info
Healthcare
CEO
info
Eric M. Green
Headquarters
info
530 Herman O. West Drive, Exton, PA, United States, 19341-1147
Employees
info
10,600
Website
info
westpharma.com
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Metrics
BasicAdvanced
Market cap
info
$15.2B
P/E ratio
info
31.45
EPS
info
$6.70
Dividend Yield
info
0.40%
Beta
info
1.22
Forward P/E ratio
info
34.6
EBIDTA
info
$749M
Ex dividend date
info
2025-04-30
Price & volume
Market cap
info
$15.2B
Average daily volume
info
0.9M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.81
Dividend yield
info
0.40%
Forward dividend per share
info
$0.84
Forward dividend yield
info
0.40%
Payout ratio
info
12.30%
Valuation
P/E ratio
info
31.45
Forward P/E
info
34.6
PEG ratio
info
3.53
Trailing P/E
info
31.45
Price to sales
info
5.26
Price to book
info
5.68
Earnings
EPS
info
$6.70
EPS estimate (current quarter)
info
$1.73
EPS estimate (next quarter)
info
$1.66
EBITDA
info
$749M
Revenues (TTM)
info
$2.89B
Revenues per share (TTM)
info
$39.63
Technicals
Beta
info
1.22
52-week High
info
$393.65
52-week Low
info
$187.43
50-day moving average
info
$239.77
200-day moving average
info
$295.67
Short ratio
info
1.45
Short %
info
2.59%
Management effectiveness
ROE (TTM)
info
17.71%
ROA (TTM)
info
9.93%
Profit margin
info
17.03%
Gross profit margin
info
$998M
Operating margin
info
22.94%
Growth
Quarterly earnings growth (YoY)
info
2.10%
Quarterly revenue growth (YoY)
info
2.30%
Share stats
Outstanding Shares
info
72.3M
Float
info
71.8M
Insiders %
info
0.59%
Institutions %
info
97.10%
Analyst Insights & forecasts
info

75% Buy

25% Hold

0% Sell

Based on information from 12 analysts.

Average price target

info
$285.01
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$1.56
$1.26
23.81%
Q1 • 24Beat
$1.52
$1.74
12.64%
Q2 • 24Beat
$1.85
$1.50
23.33%
Q3 • 24Beat
$1.82
$1.71
6.43%
Q4 • 24Beat
-
-
-
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$747M
$136M
18.21%
Q3 • 24
$749M
$130M
17.37%
Q4 • 24
0.25%
4.34%
4.58%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$3.68B
$923M
25.11%
Q3 • 24
$3.64B
$961M
26.38%
Q4 • 24
0.86%
4.13%
5.03%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$180M
$-82.1M
$-64.4M
$98.8M
Q3 • 24
$190M
$-105M
$-68.9M
$85.2M
Q4 • 24
5.55%
27.65%
6.99%
13.77%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a West Pharmaceutical Services Inc share?
Collapse

West Pharmaceutical Services Inc shares are currently traded for undefined per share.

How many shares does West Pharmaceutical Services Inc have?
Collapse

West Pharmaceutical Services Inc currently has 72.3M shares.

Does West Pharmaceutical Services Inc pay dividends?
Collapse

Yes, West Pharmaceutical Services Inc does pay dividends.

What is West Pharmaceutical Services Inc 52 week high?
Collapse

West Pharmaceutical Services Inc 52 week high is $393.65.

What is West Pharmaceutical Services Inc 52 week low?
Collapse

West Pharmaceutical Services Inc 52 week low is $187.43.

What is the 200-day moving average of West Pharmaceutical Services Inc?
Collapse

West Pharmaceutical Services Inc 200-day moving average is $295.67.

Who is West Pharmaceutical Services Inc CEO?
Collapse

The CEO of West Pharmaceutical Services Inc is Eric M. Green.

How many employees West Pharmaceutical Services Inc has?
Collapse

West Pharmaceutical Services Inc has 10,600 employees.

What is the market cap of West Pharmaceutical Services Inc?
Collapse

The market cap of West Pharmaceutical Services Inc is $15.2B.

What is the P/E of West Pharmaceutical Services Inc?
Collapse

The current P/E of West Pharmaceutical Services Inc is 31.45.

What is the EPS of West Pharmaceutical Services Inc?
Collapse

The EPS of West Pharmaceutical Services Inc is $6.70.

What is the PEG Ratio of West Pharmaceutical Services Inc?
Collapse

The PEG Ratio of West Pharmaceutical Services Inc is 3.53.

What do analysts say about West Pharmaceutical Services Inc?
Collapse

According to the analysts West Pharmaceutical Services Inc is considered a buy.